PGE2 and BMP-2 in bone and cartilage metabolism: 2 intertwining pathways

Canadian Journal of Physiology and Pharmacology

Volumn 90, Issue 11, 2012, Pages 1434-1445

  Haversath, Marcel ^a   Catelas, Isabelle ^b   Li, Xinning ^c   Tassemeier, Tjark ^a   Jäger, Marcus ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b UNIVERSITY OF OTTAWA   (Canada)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Bone morphogenetic proteins; Cellular signaling; Osteoblasts; Osteoclasts; Prostaglandins

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; PROSTAGLANDIN E2;

ARTICLE; BONE DEVELOPMENT; BONE METABOLISM; BONE REMODELING; CARTILAGE; CELL INTERACTION; FRACTURE; HETEROTOPIC OSSIFICATION; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; ORTHOPEDICS; OSTEOARTHRITIS; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; OSTEOPOROSIS; PRIORITY JOURNAL;

ANIMALS; BONE AND BONES; BONE MORPHOGENETIC PROTEIN 2; BONE REMODELING; CARTILAGE; DINOPROSTONE; HUMANS; OSTEOBLASTS; OSTEOCLASTS; SIGNAL TRANSDUCTION;

EID: 84870171076     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/y2012-123     Document Type: Article

References (72)

1. Abe, E., Yamamoto, M., Taguchi, Y., Lecka-Czernik, B., O'Brien, C.A., Economides, A.N., et al. 2000. Essential requirement of BMPs-2/4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J. Bone Miner. Res. 15(4): 663-673. doi:10.1359/jbmr.2000.15.4.663. PMID:10780858.
2. Aoyama, T., Liang, B., Okamoto, T., Matsusaki, T., Nishijo, K., Ishibe, T., et al. 2005. PGE2 signal through EP2 promotes the growth of articular chondrocytes. J. Bone Miner. Res. 20(3): 377-389. doi:10.1359/JBMR.041122. PMID:15746982.
3. Attur, M., Al-Mussawir, H.E., Patel, J., Kitay, A., Dave, M., Palmer, G., et al. 2008. Prostaglandin E2 exerts catabolic effects in osteoarthritis cartilage: evidence for signaling via the EP4 receptor. J. Immunol. 181(7): 5082-5088. PMID:18802112.
4. Bartlett, C.S., Rapuano, B.E., Lorich, D.G., Wu, T., Anderson, R.C., Tomin, E., et al. 2006. Early changes in prostaglandins precede bone formation in a rabbit model of heterotopic ossification. Bone, 38(3): 322-332. doi:10.1016/j.bone.2005.08.016. PMID:16226065.
5. Bessho, K., and Iizuka, T. 1993. Changes in bone inducing activity of bone morphogenetic protein with aging. Ann. Chir. Gynaecol. Suppl. 207: 49-53. PMID:8154837.
6. Blackwell, K.A., Hortschansky, P., Sanovic, S., Choudhary, S., Raisz, L.G., and Pilbeam, C.C. 2009. Bone morphogenetic protein 2 enhances PGE(2)-stimulated osteoclast formation in murine bone marrow cultures. Prostaglandins Other Lipid Mediat. 90 (3-4): 76-80. doi:10.1016/j.prostaglandins.2009.08.005. PMID: 19744575.
7. Blackwell, K.A., Raisz, L.G., and Pilbeam, C.C. 2010. Prostaglandins in bone: bad cop, good cop? Trends Endocrinol. Metab. 21(5): 294-301. doi:10.1016/j.tem.2009.12.004. PMID:20079660.
8. Blaney Davidson, E.N., Vitters, E.L., van Lent, P.L., van de Loo, F.A., van den Berg, W.B., and van der Kraan, P.M. 2007. Elevated extracellular matrix production and degradation upon bone morphogenetic protein-2 (BMP-2) stimulation point toward a role for BMP-2 in cartilage repair and remodeling. Arthritis Res. Ther. 9(5): R102. doi:10.1186/ar2305. PMID:17922907.
9. Boyle, W.J., Simonet, W.S., and Lacey, D.L. 2003. Osteoclast differentiation and activation. Nature, 423(6937): 337-342. doi: 10.1038/nature01658. PMID:12748652.
10. Bukata, S.V., Gelinas, J., Wei, X., Rosier, R.N., Puzas, J.E., Zhang, X., et al. 2004. PGE2 and IL-6 production by fibroblasts in response to titanium wear debris particles is mediated through a Cox-2 dependent pathway. J. Orthop. Res. 22(1): 6-12. doi: 10.1016/S0736-0266(03)00153-0. PMID:14656653.
11. Chen, D., Zhao, M., Harris, S.E., and Mi, Z. 2004. Signal transduction and biological functions of bone morphogenetic proteins. Front. Biosci. 9(1-3): 349-358. doi:10.2741/1090. PMID:14766372.
12. Chikazu, D., Li, X., Kawaguchi, H., Sakuma, Y., Voznesensky, O.S., Adams, D.J., et al. 2002. Bone morphogenetic protein 2 induces cyclo-oxygenase 2 in osteoblasts via a Cbfal binding site: role in effects of bone morphogenetic protein 2 in vitro and in vivo. J. Bone Miner. Res. 17(8): 1430-1440. doi:10.1359/jbmr.2002. 17.8.1430. PMID:12162497.
13. Choudhary, S., Alander, C., Zhan, P., Gao, Q., Pilbeam, C., and Raisz, L. 2008. Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist. Prostaglandins Other Lipid Mediat. 86(1-4): 35-40. doi: 10.1016/j.prostaglandins.2008.02.001. PMID:18406186.
14. Couchourel, D., Aubry, I., Delalandre, A., Lavigne, M., Martel- Pelletier, J., Pelletier, J.P., and Lajeunesse, D. 2009. Altered mineralization of human osteoarthritic osteoblasts is attributable to abnormal type I collagen production. Arthritis Rheum. 60(5): 1438-1450. doi:10.1002/art.24489. PMID:19404930.
15. Fleet, J.C., Cashman, K., Cox, K., and Rosen, V. 1996. The effects of aging on the bone inductive activity of recombinant human bone morphogenetic protein-2. Endocrinology, 137(11): 4605-4610. doi:10.1210/en.137.11.4605. PMID:8895323.
16. Garrison, K.R., Shemilt, I., Donell, S., Ryder, J.J., Mugford, M., Harvey, I., et al. 2010. Bone morphogenetic protein (BMP) for fracture healing in adults. Cochrane Database Syst. Rev. 6(6): CD006950. PMID:20556771.
17. Goekoop, R.J., Kloppenburg, M., Kroon, H.M., Frolich, M., Huizinga, T.W., Westendorp, R.G., et al. 2010. Low innate pro- duction of interleukin-1beta and interleukin-6 is associated with the absence of osteoarthritis in old age. Osteoarthritis Cartilage, 18(7): 942-947. PMID:20417290.
18. Govender, S., Csimma, C., Genant, H.K., Valentin-Opran, A., Amit, Y., Arbel, R., et al. BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group. 2002. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J. Bone Joint Surg. Am. 84-A(12): 2123-2134. PMID: 12473698.
19. Graham, S., Gamie, Z., Polyzois, I., Narvani, A.A., Tzafetta, K., Tsiridis, E., et al. 2009. Prostaglandin EP2 and EP4 receptor agonists in bone formation and bone healing: In vivo and in vitro evidence. Expert Opin. Investig. Drugs, 18(6): 746-766. doi: 10.1517/13543780902893051. PMID:19426119.
20. Hakeda, Y., Yoshino, T., Natakani, Y., Kurihara, N., Maeda, N., and Kumegawa, M. 1986. Prostaglandin E2 stimulates DNA synthesis by a cyclic AMP-independent pathway in osteoblastic clone MC3T3-E1 cells. J. Cell. Physiol. 128(2): 155-161. doi:10.1002/ jcp.1041280204. PMID:2426284.
21. Hofbauer, L.C., and Heufelder, A.E. 2001. The role of osteoprotegerin and receptor activator of nuclear factor kappaB ligand in the pathogenesis and treatment of rheumatoid arthritis. Arthritis Rheum. 44(2): 253-259. doi:10.1002/1529-0131(200102)44:2<253::AIDANR41 <3.0.CO;2-S. PMID:11229454.
22. Itoh, K., Udagawa, N., Katagiri, T., Iemura, S., Ueno, N., Yasuda, H., et al. 2001. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology, 142(8): 3656-3662. doi:10.1210/en.142.8.3656. PMID:11459815.
23. Jensen, E.D., Pham, L., Billington, C.J., Jr, Espe, K., Carlson, A.E., Westendorf, J.J., et al. 2010. Bone morphogenic protein 2 directly enhances differentiation of murine osteoclast precursors. J. Cell. Biochem. 109(4): 672-682. PMID:20039313.
24. Jurado, S., Garcia-Giralt, N., Diez-Perez, A., Esbrit, P., Yoskovitz, G., Agueda, L., et al. 2010. Effect of IL-1beta, PGE(2), and TGF-beta1 on the expression of OPG and RANKL in normal and osteoporotic primary human osteoblasts. J. Cell. Biochem. 110(2): 304-310. PMID:20225238.
25. Kamiya, N. 2011. The role of BMPs in bone anabolism and their potential targets SOST and DKK1. Curr Mol Pharmacol. 5(2): 153-163. PMID:21787290.
26. Kamolratanakul, P., Hayata, T., Ezura, Y., Kawamata, A., Hayashi, C., Yamamoto, Y., et al. 2011. Nanogel-based scaffold delivery of prostaglandin E(2) receptor-specific agonist in combination with a low dose of growth factor heals critical-size bone defects in mice. Arthritis Rheum. 63(4): 1021-1033. doi:10.1002/ art.30151. PMID:21190246.
27. Kaneko, H., Arakawa, T., Mano, H., Kaneda, T., Ogasawara, A., Nakagawa, M., et al. 2000. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone, 27(4): 479-486. doi:10.1016/S8756-3282(00)00358-6. PMID:11033442.
28. Ke, H.Z., Shen, V.W., Qi, H., Crawford, D.T., Wu, D.D., Liang, X.G., et al. 1998. Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Bone, 23(3): 249-255. doi:10.1016/S8756-3282(98)00102-1. PMID:9737347.
29. Kobayashi, Y., Take, I., Yamashita, T., Mizoguchi, T., Ninomiya, T., Hattori, T., et al. 2005. Prostaglandin E2 receptors EP2 and EP4 are down-regulated during differentiation of mouse osteoclasts from their precursors. J. Biol. Chem. 280(25): 24035-24042. doi: 10.1074/jbc.M500926200. PMID:15834134.
30. Lee, C.M., Genetos, D.C., Wong, A., and Yellowley, C.E. 2010. Prostaglandin expression profile in hypoxic osteoblastic cells. J. Bone Miner. Metab. 28(1): 8-16. doi:10.1007/s00774-009-0096-0. PMID: 19471853.
31. Li, M., Jee, W.S., Ke, H.Z., Tang, L.Y., Ma, Y.F., Liang, X.G., and Setterberg, R.B. 1995. Prostaglandin E2 administration prevents bone loss induced by orchidectomy in rats. J. Bone Miner. Res. 10(1): 66-73. doi:10.1002/jbmr.5650100111. PMID:7747632.
32. Li, T.F., Darowish, M., Zuscik, M.J., Chen, D., Schwarz, E.M., Rosier, R.N., et al. 2006. Smad3-deficient chondrocytes have enhanced BMP signaling and accelerated differentiation. J. Bone Miner. Res. 21(1): 4-16. doi:10.1359/JBMR.050911. PMID: 16355269.
33. Li, X., Ellman, M., Muddasani, P., Wang, J.H., Cs-Szabo, G., van Wijnen, A.J., and Im, H.-J. 2009. Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis. Arthritis Rheum. 60(2): 513-523. doi:10.1002/art.24258. PMID:19180509.
34. Luppen, C.A., Chandler, R.L., Noh, T., Mortlock, D.P., and Frenkel, B. 2008. BMP-2 vs. BMP-4 expression and activity in glucocorticoidarrested MC3T3-E1 osteoblasts: Smad signaling, not alkaline phosphatase activity, predicts rescue of mineralization. Growth Factors, 26(4): 226-237. doi:10.1080/08977190802277880. PMID:19021035.
35. Luther, G., Wagner, E.R., Zhu, G., Kang, Q., Luo, Q., Lamplot, J., et al. 2011. BMP-9 induced osteogenic differentiation of mesenchymal stem cells: molecular mechanism and therapeutic potential. Curr. Gene Ther. 11(3): 229-240. doi:10.2174/156652311795684777. PMID:21453282.
36. Majid, K., Tseng, M.D., Baker, K.C., Reyes-Trocchia, A., and Herkowitz, H.N. 2010. Biomimetic calcium phosphate coatings as bone morphogenetic protein delivery systems in spinal fusion. Spine J. 11(6): 560-567. PMID:20097616.
37. Mandal, C.C., Ghosh Choudhury, G., and Ghosh-Choudhury, N. 2009. Phosphatidylinositol 3 kinase/Akt signal relay cooperates with smad in bone morphogenetic protein-2-induced colony stimulating factor-1 (CSF-1) expression and osteoclast differentiation. Endocrinology, 150(11): 4989-4998. doi:10.1210/en.2009-0026. PMID:19819979.
38. Mano, M., Arakawa, T., Mano, H., Nakagawa, M., Kaneda, T., Kaneko, H., et al. 2000. Prostaglandin E2 directly inhibits boneresorbing activity of isolated mature osteoclasts mainly through the EP4 receptor. Calcif. Tissue Int. 67(1): 85-92. doi:10.1007/ s00223001102. PMID:10908419.
39. Marui, A., Hirose, K., Maruyama, T., Arai, Y., Huang, Y., Doi, K., et al. 2006. Prostaglandin E2 EP4 receptor-selective agonist facilitates sternal healing after harvesting bilateral internal thoracic arteries in diabetic rats. J. Thorac. Cardiovasc. Surg. 131(3): 587-593. doi:10.1016/j.jtcvs.2005.10.026. PMID:16515909.
40. Minamizaki, T., Yoshiko, Y., Kozai, K., Aubin, J.E., and Maeda, N. 2009. EP2 and EP4 receptors differentially mediate MAPK pathways underlying anabolic actions of prostaglandin E2 on bone formation in rat calvaria cell cultures. Bone, 44(6): 1177-1185. doi:10.1016/j.bone.2009.02.010. PMID:19233324.
41. Naik, A.A., Xie, C., Zuscik, M.J., Kingsley, P., Schwarz, E.M., Awad, H., et al. 2009. Reduced COX-2 expression in aged mice is associated with impaired fracture healing. J. Bone Miner. Res. 24(2): 251-264. doi:10.1359/jbmr.081002. PMID:18847332.
42. Nakagawa, K., Imai, Y., Ohta, Y., and Takaoka, K. 2007. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation. Bone, 41(4): 543-548. doi:10.1016/ j.bone.2007.06.013. PMID:17681894.
43. Narumiya, S., Sugimoto, Y., and Ushikubi, F. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79(4): 1193-1226. PMID:10508233.
44. Nishitani, K., Ito, H., Hiramitsu, T., Tsutsumi, R., Tanida, S., Kitaori, T., et al. 2010. PGE2 inhibits MMP expression by suppressing MKK4-JNK MAP kinase-c-JUN pathway via EP4 in human articular chondrocytes. J. Cell. Biochem. 109(2): 425-433. PMID: 19998410.
45. O'Keefe, R.J., Tiyapatanaputi, P., Xie, C., Li, T.F., Clark, C., Zuscik, M.J., et al. 2006. COX-2 has a critical role during incorporation of structural bone allografts. Ann. N. Y. Acad. Sci. 1068(1): 532-542. doi:10.1196/annals.1346.012. PMID:16831949.
46. Paralkar, V.M., Borovecki, F., Ke, H.Z., Cameron, K.O., Lefker, B., Grasser, W.A., et al. 2003. An EP2 receptor-selective prostaglandin E2 agonist induces bone healing. Proc. Natl. Acad. Sci. U.S.A. 100(11): 6736-6740. doi:10.1073/pnas.1037343100. PMID:12748385.
47. Queally, J.M., Devitt, B.M., Butler, J.S., Malizia, A.P., Murray, D., Doran, P.P., and O'Byrne, J.M. 2009. Cobalt ions induce chemokine secretion in primary human osteoblasts. J. Orthop. Res. 27(7): 855-864. doi:10.1002/jor.20837. PMID:19132727.
48. Rapuano, B.E., Boursiquot, R., Tomin, E., Macdonald, D.E., Maddula, S., Raghavan, D., et al. 2008. The effects of COX-1 and COX-2 inhibitors on prostaglandin synthesis and the formation of heterotopic bone in a rat model. Arch. Orthop. Trauma Surg. 128(3): 333-344. doi:10.1007/s00402-007-0436-2. PMID:18034350.
49. Rihn, J.A., Patel, R., Makda, J., Hong, J., Anderson, D.G., Vaccaro, A.R., et al. 2009. Complications associated with single-level transforaminal lumbar interbody fusion. Spine J. 9(8): 623-629. doi: 10.1016/j.spinee.2009.04.004. PMID:19482519.
50. Ryoo, H.M., Lee, M.H., and Kim, Y.J. 2006. Critical molecular switches involved in BMP-2-induced osteogenic differentiation of mesenchymal cells. Gene, 366(1): 51-57. doi:10.1016/j.gene. 2005.10.011. PMID:16314053.
51. Sakuma, Y., Li, Z., Pilbeam, C.C., Alander, C.B., Chikazu, D., Kawaguchi, H., and Raisz, L.G. 2004. Stimulation of cAMP production and cyclooxygenase-2 by prostaglandin E(2) and selective prostaglandin receptor agonists in murine osteoblastic cells. Bone, 34(5): 827-834. doi:10.1016/j.bone.2003.12.007. PMID:15121014.
52. Sampath, T.K., Coughlin, J.E., Whetstone, R.M., Banach, D., Corbett, C., Ridge, R.J., et al. 1990. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-beta superfamily. J. Biol. Chem. 265(22): 13198-13205. PMID:2376592.
53. Schmitt, B., Ringe, J., Haupl, T., Notter, M., Manz, R., Burmester, G.R., et al. 2003. BMP2 initiates chondrogenic lineage development of adult human mesenchymal stem cells in high-density culture. Differentiation, 71(9 -10): 567-577. doi:10.1111/j.1432-0436.2003.07109003.x. PMID:14686954.
54. Shimpo, H., Sakai, T., Kondo, S., Mishima, S., Yoda, M., Hiraiwa, H., and Ishiguro, N. 2009. Regulation of prostaglandin E(2) synthesis in cells derived from chondrocytes of patients with osteoarthritis. J. Orthop. Sci. 14(5): 611-617. doi:10.1007/s00776-009-1370-7. PMID:19802674.
55. Suda, M., Tanaka, K., Yasoda, A., Natsui, K., Sakuma, Y., Tanaka, I., et al. 1998. Prostaglandin E2 (PGE2) autoamplifies its production through EP1 subtype of PGE receptor in mouse osteoblastic MC3T3-E1 cells. Calcif. Tissue Int. 62(4): 327-331. doi:10.1007/ s002239900440. PMID:9504958.
56. Toth, J.M., Boden, S.D., Burkus, J.K., Badura, J.M., Peckham, S.M., and McKay, W.F. 2009. Short-term osteoclastic activity induced by locally high concentrations of recombinant human bone morphogenetic protein-2 in a cancellous bone environment. Spine, 34(6): 539-550. doi:10.1097/BRS.0b013e3181952695. PMID: 19240666.
57. Toyoda, H., Terai, H., Sasaoka, R., Oda, K., and Takaoka, K. 2005. Augmentation of bone morphogenetic protein-induced bone mass by local delivery of a prostaglandin E EP4 receptor agonist. Bone, 37(4): 555-562. doi:10.1016/j.bone.2005.04.042. PMID:16027058.
58. Tseng, W.P., Yang, S.N., Lai, C.H., and Tang, C.H. 2010. Hypoxia induces BMP-2 expression via ILK, Akt, mTOR, and HIF-1 pathways in osteoblasts. J. Cell. Physiol. 223(3): 810-818. PMID: 20232298.
59. Tsuji, K., Bandyopadhyay, A., Harfe, B.D., Cox, K., Kakar, S., Gerstenfeld, L., et al. 2006. BMP2 activity, although dispensable for bone formation, is required for the initiation of fracture healing. Nat. Genet. 38(12): 1424-1429. doi:10.1038/ng1916. PMID:17099713.
60. Tsutsumi, R., Xie, C., Wei, X., Zhang, M., Zhang, X., Flick, L.M., et al. 2009. PGE2 signaling through the EP4 receptor on fibroblasts upregulates RANKL and stimulates osteolysis. J. Bone Miner. Res. 24(10): 1753-1762. doi:10.1359/jbmr.090412. PMID: 19419302.
61. Turgeman, G., Zilberman, Y., Zhou, S., Kelly, P., Moutsatsos, I.K., Kharode, Y.P., et al. 2002. Systemically administered rhBMP-2 promotes MSC activity and reverses bone and cartilage loss in osteopenic mice. J. Cell. Biochem. 86(3): 461-474. doi:10.1002/ jcb.10231. PMID:12210753.
62. Urist, M.R. 1965. Bone: formation by autoinduction. Science, 150(3698): 893-899. doi:10.1126/science.150.3698.893. PMID: 5319761.
63. van der Kraan, P.M., Davidson, E.N., and van den Berg, W.B. 2010. Bone morphogenetic proteins and articular cartilage: to serve and protect or a wolf in sheep clothing's? Osteoarthritis Cartilage, 18(6): 735-741. doi:10.1016/j.joca.2010.03.001. PMID:20211748.
64. Wang, E.A., Rosen, V., D'Alessandro, J.S., Bauduy, M., Cordes, P., Harada, T., et al. 1990. Recombinant human bone morphogenetic protein induces bone formation. Proc. Natl. Acad. Sci. U.S.A. 87(6): 2220-2224. doi:10.1073/pnas.87.6.2220. PMID:2315314.
65. -/- mice via activation of prostaglandin E2 receptor subtype 4. Am. J. Pathol. 175(2): 772-785. doi:10.2353/ajpath.2009.081099. PMID: 19628768.
66. Xu, J., Li, X., Lian, J.B., Ayers, D.C., and Song, J. 2009. Sustained and localized in vitro release of BMP-2/7, RANKL, and tetracycline from FlexBone, an elastomeric osteoconductive bone substitute. J. Orthop. Res. 27(10): 1306-1311. doi:10.1002/jor.20890. PMID:19350632.
67. Yamaguchi, T., Takada, Y., Maruyama, K., Shimoda, K., Arai, Y., Nango, N., et al. 2009. Fra-1/AP-1 impairs inflammatory responses and chondrogenesis in fracture healing. J. Bone Miner. Res. 24(12): 2056-2065. doi:10.1359/jbmr.090603. PMID:19558315.
68. Yoshida, K., Oida, H., Kobayashi, T., Maruyama, T., Tanaka, M., Katayama, T., et al. 2002. Stimulation of bone formation and prevention of bone loss by prostaglandin E EP4 receptor activation. Proc. Natl. Acad. Sci. U.S.A. 99(7): 4580-4585. doi: 10.1073/pnas.062053399. PMID:11917107.
69. Yumoto, K., Ishijima, M., Rittling, S.R., Tsuji, K., Tsuchiya, Y., Kon, S., et al. 2002. Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. U.S.A. 99(7): 4556-4561. doi: 10.1073/pnas.052523599. PMID:11930008.
70. Zhang, X., Schwarz, E.M., Young, D.A., Puzas, J.E., Rosier, R.N., and O'Keefe, R.J. 2002. Cyclooxygenase-2 regulates mesenchymal cell differentiation into the osteoblast lineage and is critically involved in bone repair. J. Clin. Invest. 109(11): 1405-1415. PMID:12045254.
71. Zhang, M., Ho, H.C., Sheu, T.J., Breyer, M.D., Flick, L.M., Jonason, J.H., et al. 2011. EP1(-/-) mice have enhanced osteoblast differentiation and accelerated fracture repair. J. Bone Miner. Res. 26(4): 792-802. doi:10.1002/jbmr.272. PMID:20939055.
72. Zhou, S., Turgeman, G., Harris, S.E., Leitman, D.C., Komm, B.S., Bodine, P.V., and Gazit, D. 2003. Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells. Mol. Endocrinol. 17(1): 56-66. doi:10.1210/me.2002- 0210. PMID:12511606.